Primary Peritoneal Carcinoma Terminated Phase 1 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02661815A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological CancerTreatment
NCT01202890Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTreatment